# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-053028
Filing Date
2025-04-11
Accepted
2025-04-11 07:42:06
Documents
32
Period of Report
2025-04-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | lrmr-20250409.htm iXBRL | DEF 14A | 1637667
2 | GRAPHIC | img133695856_0.jpg | GRAPHIC | 37855
3 | GRAPHIC | img133695856_1.jpg | GRAPHIC | 37855
4 | GRAPHIC | img133695856_2.jpg | GRAPHIC | 16328
5 | GRAPHIC | img133695856_3.jpg | GRAPHIC | 69446
6 | GRAPHIC | img133695856_4.jpg | GRAPHIC | 37855
7 | GRAPHIC | img133695856_5.jpg | GRAPHIC | 74057
8 | GRAPHIC | img133695856_6.jpg | GRAPHIC | 20543
9 | GRAPHIC | img133695856_7.jpg | GRAPHIC | 21702
10 | GRAPHIC | img133695856_8.jpg | GRAPHIC | 20314
11 | GRAPHIC | img133695856_9.jpg | GRAPHIC | 18336
12 | GRAPHIC | img133695856_10.jpg | GRAPHIC | 1252402
13 | GRAPHIC | img133695856_11.jpg | GRAPHIC | 943974
14 | GRAPHIC | img133695856_12.jpg | GRAPHIC | 160922
15 | GRAPHIC | img133695856_13.jpg | GRAPHIC | 208978
16 | GRAPHIC | img133695856_14.jpg | GRAPHIC | 33737
17 | GRAPHIC | img133695856_15.jpg | GRAPHIC | 33737
18 | GRAPHIC | img133695856_16.jpg | GRAPHIC | 33737
19 | GRAPHIC | img133695856_17.jpg | GRAPHIC | 403860
20 | GRAPHIC | img133695856_18.jpg | GRAPHIC | 254421
| Complete submission text file | 0000950170-25-053028.txt |  | 12049475

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
21 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | lrmr-20250409.xsd | EX-101.SCH | 7740
34 | EXTRACTED XBRL INSTANCE DOCUMENT | lrmr-20250409_htm.xml | XML | 543740

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36510 | Film No.: 25829872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)